Back to Search Start Over

Statistical Design and Optimization of Sustained Release Formulations of Pravastatin.

Authors :
Gunda RK
Manchineni PR
Source :
Turkish journal of pharmaceutical sciences [Turk J Pharm Sci] 2020 Apr; Vol. 17 (2), pp. 221-227. Date of Electronic Publication: 2020 Apr 24.
Publication Year :
2020

Abstract

Objectives: The objective of the current study was to formulate a sustained release (SR) formulation for pravastatin. Pravastatin is a lipid lowering, biopharmaceutical classification class-III agent.<br />Materials and Methods: SR tablets of pravastatin were prepared using variable amounts of hydroxy methyl propyl cellulose (HPMC) K4M and sodium carboxy methyl cellulose in various proportions by direct compression in a 3 <superscript>2</superscript> factorial design. The amounts of the polymers HPMC K4M and sodium carboxy methyl cellulose required to obtain prolonged release of drug were chosen as independent variables, X <subscript>1</subscript> and X <subscript>2</subscript> , respectively, whereas times taken for 10%, 50%, 75%, and 90% drug release were chosen as dependent variables.<br />Results: Nine formulations were developed and were checked using pharmacopoeial tests. The results showed that all the factorial batches were within the standard limits. The dissolution parameters of all formulations were subjected to kinetic fitting and various statistical parameters were determined. Polynomial equations were developed and verified for dependent variables. Formulation F <subscript>5</subscript> , containing 25 mg of HPMC K4M and 25 mg of sodium carboxy methyl cellulose, was the formulation most similar (similarity factor f <subscript>2</subscript> =89.559, difference factor f <subscript>1</subscript> =1.546) to the marketed product (Pravachol).<br />Conclusion: The best formulation (F <subscript>5</subscript> ) follows Higuchi's kinetics and non-Fickian diffusion zero order kinetics (n=1.083).<br />Competing Interests: Conflicts of interest: No conflict of interest was declared by the authors. The authors alone are responsible for the content and writing of the paper.<br /> (©Copyright 2020 Turk J Pharm Sci, Published by Galenos Publishing House.)

Details

Language :
English
ISSN :
2148-6247
Volume :
17
Issue :
2
Database :
MEDLINE
Journal :
Turkish journal of pharmaceutical sciences
Publication Type :
Academic Journal
Accession number :
32454783
Full Text :
https://doi.org/10.4274/tjps.galenos.2019.70048